"Designing Growth Strategies is in our DNA"

Next-Generation Sequencing (NGS) Market Size, Share and Industry Analysis By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Regional Forecast, 2019 - 2026

Region : Global | Format: PDF | Report ID: FBI101000

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

Global Next-Generation Sequencing Market size was valued at US$ 6,335.2 Mn in 2018 and is Projected to Reach US$ 31,411.3 Mn by 2026, Exhibiting a CAGR of 22.2% between 2018 and 2026.

COVID-19 Cover

We are in process of revamping Next-Generation Sequencing (NGS) Market with respect to COVID-19 Impact.

Inquire before buying

The growing demand for fast, cost-effective, and accurate DNA sequencing data interpretation has resulted in the birth and dominance of NGS industry, as it allows the sequencing of massive amount of DNA in a single run, thus facilitating the diagnosis of diseases and research. One of the major contributions of next-generation sequencing is genomics. The initiation of genomics projects in various countries such as the U.K., Qatar, and others is anticipated to favour this market. Also, the emergence of NGS-based diagnostics and active government support for the same are the major factors for the expansion of the market.


 

Request a Free sample to learn more about this report.


Key Market Drivers


Diversified Applications of Next-Generation Sequencing in Diagnostics, are Driving the Market


The lowered cost of sequencing has resulted in increasing the application of NGS in diagnosis of diseases. Various test kits and testing services are emerging for the non-invasive pre-natal testing, cancer diagnosis, genetic testing, and others, which is driving the global market. Moreover, the active government support through product approval and improved reimbursement coverage for such diagnostic tests is expected to provide new market growth opportunities. In addition, rising prevalence of chronic diseases, increased research, and start of high budget genomics projects is anticipated to further fuel the market growth during the forecast period.


Market Segmentation


 

To know how our report can help streamline your business, Speak to Analyst


Next-generation sequencing products include both instruments, software, and consumables. The product segment is estimated to dominate the market throughout the forecast period. The primary reasons responsible for its growth are the easy availability, high volume usage of consumables, and new product launch. The emerging need for new platform for accurate DNA data interpretation and advancements in bioinformatics has successfully contributed to increasing the number of startups for NGS software and services. This has also rendered the services as the most attractive and lucrative segment in the NGS market. The services segment is anticipated to have a remarkable growth during the forecast period owing to the decrease in cost of sequencing through NGS, rapid adoption of genetic test, emerging guidelines, and health reimbursement policies. In terms of application, the market is divided into diagnostics, research and others. The diagnosis segment is estimated to account for a major portion of the next-generation sequencing market owing to the increasing adoption of genetic test, demand for cancer diagnosis, and increase in number of service providers. In May 2018, Centers for Medicare & Medicaid Services (CMS) announced the National Coverage Determination to cover next-generation sequencing-based laboratory test for patients having cancer, which is projected to accelerate the growth of diagnosis segment. Various end users covered under the report are research institutes, healthcare facilities & diagnostic centres, pharmaceutical & biotechnological companies, and Contract Research Organization (CROs).


Regional Analysis


 

North America Next-Generation Sequencing Market Size, 2018

To get more information on the regional analysis of this market, Request a Free sample


North America to Dominate the Market


North America dominated the next-generation sequencing market share in 2018. The market in the region was valued at US$ 2,331.4 Mn in 2018. The active government support, direct presence of major manufacturers, and rising prevalence of cancer are the major factors for the expansion of the market in North America in the forecast duration. In September 2018, the FDA granted marketing approval for ClonoSEQ assay, a next-generation sequencing-based diagnostic test for minimal residual disease (MRD), in patients having acute lymphoblastic leukemia (ALL) or multiple myeloma, which is expected to augment the market in North America. In Europe, the market is estimated to expand owing to the increasing research investment, emphasis of precision medicines, and strategic collaborations. However, Asia Pacific is projected to report a remarkable growth owing to the increasing research activities, rising prevalence of genetic disorders, awareness on reproductive health, and improving healthcare infrastructure. The market in Latin America and Middle East & Africa is projected to register moderate CAGR during 2019-2026.


Key Players


Illumina, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc., to Account for the Largest Market Share in Terms of Revenue


Illumina, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc., are estimated to acquire leading position in this market owing to their diversified product portfolio, strong geographical presence, and strategic partnerships. Illumina, Inc. acquired the top position in the market owing to the increasing sales of its products. In November 2017, Illumina announced the launch of NextSeq 550Dx instrument, the company’s second FDA approved and CE marked NGS platform to diversify its diagnostic NGS product portfolio and strengthening its position in the next-generation sequencing market. Other key market players operating in the global market are Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx, and others.


Next-Generation Sequencing (NGS) Market Players



Report Coverage 


Sequencing of DNA fragments have helped in the diagnosis of diseases, research, drug discovery, forensics, and others. Next-generation sequencing, also called as high through-put sequencing is a useful platform that enables the sequencing of millions of DNA molecules simultaneously. The demand for next-generation sequencer is booming drastically, owing to its advantage of sequencing millions of DNA fragments in a single run. Many of the upcoming genetic tests such as Non-invasive Prenatal Testing (NIPT), Preimplantation Genetic Testing (PGT), virology, molecular testing, cancer diagnosis, and others are based on this technology. The increasing clinical application of NGS, increasing research, initiation of genome projects in various countries, adoption of personalized medicines, and advancements in bioinformatics are expected to further boost the market.


The next-generation sequencing market report provides qualitative and quantitative insights on the industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market segments include type, application, end user, and region. Based on type, this market is segmented into products and services. The products segment is further bifurcated into instruments & software and consumables. In terms of application, the market is divided into diagnostics, research, and others. Various end users covered under the report are research institutes, healthcare facilities & diagnostic centers, pharmaceutical & biotechnological companies, Contract Research Organization (CROs). Geographically, the market is segmented into four major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.


 

To gain extensive insights into the market, Request for Customization


Along with this, the NGS market report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the overview of diagnostic tests, new product launch, regulatory scenario for key countries, startups with their funding overview, recent industry developments such as mergers & acquisitions, and key industry trends.


Segmentation


























 ATTRIBUTE


 DETAILS

By Type




  • Products

  • Instruments & Software

  • Consumables

  • Services



By Application




  • Diagnostics

  • Research

  • Others



By End User




  • Research Institutes

  • Healthcare Facilities & Diagnostic Centers

  • Pharmaceutical & Biotechnological Companies

  • Contract Research Organization (CROs)



By Geography




  • North America (the USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)



Key Industry Developments



  • In June 2019, Saphetor announced its partnership with Swift Biosciences Inc. aiming to accelerate and standardize data interpretation solution for targeted next-generation sequencing panels.

  • In January 2019, PierianDx announced partnership with Illumina to provide the customers with informatics services for Illumina’s oncology products further supporting cancer diagnostics and research.  

  • In November 2017, Illumina, announced the launch of NextSeq 550Dx instrument, the company’s second FDA and CE marked NGS platform to diversify its diagnostic product portfolio.

  • In September 2018, the FDA granted marketing approval to ClonoSEQ assay, a next-generation sequencing-based diagnostic test developed by Adaptive Biotechnologies Corp. for minimal residual disease (MRD), in patients having acute lymphoblastic leukemia (ALL) or multiple myeloma

  • In June 2018, Agilent Technologies announced the launch of Agilent OnePGT, a NGS solution for Preimplantation Genetic Testing (PGT).


Frequently Asked Questions

Fortune Business Insights says that the market is projected to reach USD 31,411.3 Million by 2026.

In 2018, the global market was valued at USD 6,335.2 Million.

Growing at a CAGR of 22.2%, the market will exhibit faster growth in the forecast period (2019-2026).

Next-generation sequencing product segment is expected to be leading in the market during the forecast period.

Diversified applications of NGS in diagnostics will drive the global market.

Illumina, Inc., F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific Inc. are the top players in this market.

North America is expected to hold the highest share in the market.

Strong potential for the growth of precision medicine, DNA sequencing libraries and NGS library preparation are the trends expected to increase the market value of next-generation sequencing.

Next-Generation Sequencing (NGS) Market Size, Share and Global Industry Trend Forecast till 2026
  • Jul, 2019
  • 2018
  • 2015-2017
  • 145

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X